Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: The Topical Niacin Skin Flush Test in First Episode Psychosis
A clinical trial evaluating a topical niacin skin flush test for first-episode psychosis and schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Acute Psychological Effects of High Intensity Exercise With Schizophrenia [NA]
A completed clinical trial assessing the acute psychological effects of high-intensity exercise in people with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant [Phase 1]
Phase 1 SBIR-funded trial update for OnTrack, an online role-playing game for psychosis-spectrum disorders, which has completed.
-
CLINICAL_TRIALS withdrawal · 2016-07-20Clinical Trial Update: Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients [NA]
The trial evaluating non-invasive brain stimulation for medication-resistant auditory hallucinations in schizophrenia has been withdrawn.
-
CLINICAL_TRIALS research · 2016-07-15Clinical Trial Update: fMRI of Theory of Mind in Schizophrenia and Bipolar Disorder [NA]
An fMRI study examining Theory of Mind in schizophrenia and bipolar disorder, with the current trial status listed as unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder [Phase 1]
Clinical trial update indicating completion of Phase 1 evaluation of aripiprazole lauroxil in adults with schizophrenia or schizoaffective d…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating safety, tolerability, and pharmacokinetics of APN1125 in schizophrenia. The study status is curre…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating artemisinin in combination with risperidone for first-episode and drug-naive schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia [NA]
A double-blind, randomized trial studied adding celecoxib to risperidone in treatment-naive first-episode schizophrenia; the study has compl…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia [NA]
A completed randomized double-blind trial evaluated six antipsychotic drugs for schizophrenia; no specific results are provided in the updat…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Melatonin Treatment for Tardive Dyskinesia in Schizophrenia [NA]
This completed clinical trial evaluated melatonin as a treatment for tardive dyskinesia in individuals with schizophrenia.
-
CLINICAL_TRIALS research · 2016-07-12Clinical Trial Update: Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia [Phase 3]
An update on a Phase 3 clinical trial evaluating memantine added to standard treatment for cognitive and negative symptoms in schizophrenia.…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Ginkgo Biloba Extract for Schizophrenia [NA]
The document reports that a clinical trial evaluating ginkgo biloba extract for schizophrenia has completed. No results are provided in the …
-
FDA approval · 2016-07-08FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) submitted by Sumitomo Pharma America, Inc.
-
FDA approval · 2016-06-30FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for HALOPERIDOL DECANOATE from Fresenius Kabi USA, LLC (ANDA074893). The approval denotes regulatory…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Minocycline for Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating minocycline for schizophrenia has completed; the provided snippet does not include trial results.
-
CLINICAL_TRIALS research · 2016-06-21Clinical Trial Update: Emotions in Schizophrenia and Bipolar Disorders: a Common Vulnerability? [NA]
A clinical trial entry (NCT02805088) from CHU de Reims investigating emotional processing in schizophrenia and bipolar disorder, with the st…
-
FDA approval · 2016-06-17FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP. This action modifies the product l…
-
CLINICAL_TRIALS research · 2016-06-17Clinical Trial Update: The Use of Skills Training to Augment Compensated Work Therapy (CWT)/VI for Veterans With SMI [NA]
A completed clinical trial evaluating skills training to augment Compensated Work Therapy/VI for veterans with serious mental illness, inclu…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Lifestyle Intervention for Diabetes and Weight Management in Psychosis [NA]
A completed clinical trial evaluating a lifestyle intervention for diabetes management and weight loss in individuals with psychotic disorde…
-
CLINICAL_TRIALS research · 2016-06-15Clinical Trial Update: Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM) [NA]
Completed clinical trial evaluating a group intervention aimed at improving coping with stigma and empowerment for people with schizophrenia…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia [Phase 1]
Phase 1 study reporting multiple ascending doses of PF-04958242 in subjects with stable schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients [Phase 1]
Phase 1 study in adolescents assessed tolerability and pharmacokinetics of iloperidone, reporting on safety and how the drug is processed in…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: The Efficacy of REHACOP Program in Schizophrenia [NA]
Completed clinical trial evaluating the efficacy of the REHACOP cognitive rehabilitation program in individuals with schizophrenia.
-
CLINICAL_TRIALS research · 2016-06-08Clinical Trial Update: Understanding and Helping Families: Parents With Psychosis [NA]
A ClinicalTrials.gov record for a University of Manchester study on parenting in individuals with psychosis (including schizophrenia) with a…